NCT00236145View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2005

Conditions
Breakthrough Pain
Interventions
DRUG

ACTIQ (Oral transmucosal fentanyl citrate)

Sponsors

Lead Sponsor

Cephalon
All Listed Sponsors
lead

Cephalon

INDUSTRY